Skip to content

Clinical trials

Recruiting Lymphoma, B-Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Status: Recruiting Country / region: China Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20213
20223
20237
202415
202524
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting61

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Ruijin Hospital3
Second Affiliated Hospital, Zhejiang University, School of Medicine3
Shenzhen University General Hospital3
Aibin Liang,MD,Ph.D.2
Anhui Provincial Hospital2
BeOne Medicines2
Chinese PLA General Hospital2
Chongqing Precision Biotech Co., Ltd2
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell61
Recurrence11
Lymphoma, Non-Hodgkin8
Burkitt Lymphoma5
Lymphoma, Follicular5
Multiple Myeloma5
Leukemia, Lymphocytic, Chronic, B-Cell4
Leukemia, Myeloid, Acute4
Lymphoma, Mantle-Cell4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.